Signaling Pathway
Trevotamig is a bispecific antibody designed to target EPCAM and CD3E. This dimer-type antibody is engineered from the H-??1_L-??-scFvhl framework, offering precise dual specificity. It facilitates targeted immunotherapy by engaging both tumor cells and T-cells, making it a valuable tool for research in cancer immunology and therapeutic development.
重要通知：仅供研究使用。我们不向患者销售。
| Discription | Trevotamig is a bispecific antibody designed to target EPCAM and CD3E. This dimer-type antibody is engineered from the H-??1_L-??-scFvhl framework, offering precise dual specificity. It facilitates targeted immunotherapy by engaging both tumor cells and T-cells, making it a valuable tool for research in cancer immunology and therapeutic development. |
||
|---|---|---|---|
| Targets |
|
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2
